North East and North Cumbria
ICS Formulary
ICS Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-04-01-02 5-Alpha reductase inhibitors
| Dutasteride |
|
Formulary
|
|
 MHRA Drug Safety Update (May 2026): Finasteride and Dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunction |
|
| Finasteride |
|
Formulary
|
|
|
MHRA Drug Safety Update (May 2026): Finasteride and Dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunction |
|
|
Links
- County Durham and Darlington Adult Bladder and Bowel formulary First Line Prescribing Guide 2023
- MHRA Drug Safety Update (May 2026): Finasteride and Dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunction
- MHRA Drug Safety Update (May 2026): Finasteride and Dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunction
- NICE NG118: Renal and ureteric stones: assessment and management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG126: Ectopic pregnancy and miscarriage: diagnosis and initial management
North of Tyne, Gateshead and North Cumbria Urinary Continence Enablement Products and Devices Formulary Guideline (October 2024)- Tees Urinary Continence Formulary February 2020